■ Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen et al
Alzheimer & Dementia 2017, vol 13 (3): 274-284
http://www.alzheimersanddementia.com/article/S1552-5260(16)32963-6/fulltext
■ Alzheimer´s disease can be treated: Why the delay?
Harry S. Goldsmith
Surg Neurol Int. 2017; 8: 133.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523480/
■ Is cognitive decline measurable in preclinical Alzheimer´s disease?
Sandra Weintraub, Christopher Randolph, Lisa Bain et al
Alzheimer & Dementia 2017, vol 13 (3: 322-323
http://www.alzheimersanddementia.com/article/S1552-5260(17)30052-3/fulltext
■ Targeting functional decline: results from the Alzhemier´s disease multiple intervention trial
Christopher M. Callahan, Malaz A. Boustani, Arlene A. Schmid et al
Ann Intern Med. 2017 , vol 7; 166(3): 164–171.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554402/
■ Considering sex and gender in Alzheimer disease and other dementias
Jessica L. Podcasy, C. Neill Epperson
Dialogues Clin Neurosci. 2016 Dec; 18(4): 437–446.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286729/
■ Alzheimer disease makes new blood contacts
Mario Merlini, Katerina Akassoglou
Blood. 2017, vol 129(18): 2462–2463.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418641/
■ Update on a patient with Alzheimer disease treated with CT Scans
Jerry M. Cuttler, Eugene R. Moore, Victor D. Hosfeld, David L. Nadolski
Dose Response. 2017 Jan-Mar; 15(1): 1559325817693167
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347268/
■ Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center Database
John M. Ringman, Sarah Monsell, Denise W. Ng et al
J Neuropathol Exp Neurol. 2016 Mar; 75(3): 284–290
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934612/
■ Music therapy is a potential intervention for cognition of Alzhemier´s disease: a mini-review
Rong Fang, Shengxuan Ye, Jiangtao Huangfu, David P. Calimag
Transl Neurodegener. 2017; 6: 2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267457/
■ Diagnosing the frontal variant of Alzheimer´s disease: a clinician´s yellow brick road
Russell P. Sawyer, Federico Rodriguez-Porcel, Matthew Hagen, Rhonna Shatz, Alberto J. Espay
J Clin Mov Disord. 2017; 4: 2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333400/
■ Blood-based biomarkers in Alzheimer disease: current state of the Science and a novel collaborative paradigma for advancing from Discovery to clinic
Sid E. O’Bryant, Michelle M. Mielke, Robert A. Rissman et al
the Biofluid Based Biomarker Professional Interest Area
Alzheimer & Dementia 2017, vol 13 (7): 727-738
http://www.alzheimersanddementia.com/article/S1552-5260(16)33056-4/fulltext
■ Association of blood lipids with Alzheimer´s disease: a comprehensive lipidomics analysis
Petroula Proitsi, Min Kim, Luke Whiley et al
Alzheimer & Dementia 2017, vol 13 (2): 140-151
http://www.alzheimersanddementia.com/article/S1552-5260(16)30022-X/fulltext
■ Defining imaging biomarker cut points for brain aging and Alzheimer´s disease
Clifford R. Jack Jr., Heather J. Wiste, Stephen D. Weigand et al
Alzheimer & Dementia 2017, vol 13 (3): 205-216
http://www.alzheimersanddementia.com/article/S1552-5260(16)32875-8/fulltext
■ Visual and ocular manifestations of Alzheimer´s disease and their use as biomarkers for diagnosis and progression
Fatimah Zara Javaid, Jonathan Brenton, Li Guo, Maria F. Cordeiro
Front Neurol. 2016; 7: 55
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836138/
■ Assessing the economic burden of Alzheimer´s disease patients first diagnosed by specialists
Noam Y. Kirson, Urvi Desai, Ljubica Ristovska et al
BMC Geriatr. 2016; 16: 138.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940962/
■ Adaptive working memory strategy training in early Alzheimer´s disease: randomised controlled trial
J D Huntley, A Hampshire, D Bort et al
The British Journal of Psychiatry 2017: 61-66
http://bjp.rcpsych.org/content/210/1/61
■ Regional cerebral blood flow in mild cognitive impairment and Alzheimer´s disease measured with arterial spin labeling magnetic resonance imaging
Alba Sierra-Marcos
Int J Alzheimers Dis. 2017; 2017: 5479597
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442339/
■ Comparative analysis of the electroencephalogram in patients with Alzheimer’s disease, diffuse axonal injury patients and healthy controls using LORETA analysis.
Ianof, Jéssica Natuline et al.
Dement. neuropsychol., June 2017, vol.11, no.2, p.176-185
■ Type 2 diabetes mellitus in the pathophysiology of Alzheimer’s disease
Nazareth, Aparecida Marcelino de.
Dement. neuropsychol., June 2017, vol.11, no.2, p.105-113
■ Antidiabetic drugs in Alzheimer´s disease: mechanisms of action and future perspectves
D Femminella, L Bencivenga, L Petraglia et al
Journal of Diabetes Research 2017, (2017), ID 7420796, 7 pages
https://www.hindawi.com/journals/jdr/2017/7420796/
■ Planning ability impairments in probable Alzheimer’s disease patients: Evidence from the Tower of London test.
Satler, Corina, Guimarães, Luiza and Tomaz, Carlos
Dement. neuropsychol., June 2017, vol.11, no.2, p.137-144
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200137&lng=pt&nrm=iso
■ Cross-cultural adaptation of the “Australian National University Alzheimer’s Disease Risk Index” for the Brazilian population
Borges, Marcus Kiiti, Jacinto, Alessandro Ferrari and Citero, Vanessa de Albuquerque
Dement. neuropsychol., June 2017, vol.11, no.2, p.162-175
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200162&lng=pt&nrm=iso
■ Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer’s disease in Chile.
Musa, Gada et al.
Dement. neuropsychol., June 2017, vol.11, no.2, p.129-136
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000200129&lng=pt&nrm=iso
■ The association of antidepressant drug usage with cognitive impairment or dementia, incluing Alzheimer´s disease: a systematic review and meta-analysis
J Moraros, C Nwankwo, SB Pattern, D D Mousseasu
Anxiety & Depression 2017, vol 34: 217-226
http://onlinelibrary.wiley.com/doi/10.1002/da.22584/full
■ Early diagnosis of mild cognitive impairment and Alzheimer´s disease based on salivar latoferrin
Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja et al
Alzheimers Dement (Amst) 2017; 8: 131–138
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470603/
■ Longitudinal evaluation of critereia for subjective cognitive decline and preclinical Alzheimer´s disease in a memory clinic sample
Marie Eckerström, Mattias Göthlin, Sindre Rolstad et al
Alzheimers Dement (Amst) 2017; 8: 96–107.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443895/
■ Resting-state network dysfunction in Alzheimer´s disease: a systematic review and meta-analysis
AmanPreet Badhwar, Angela Tam, Christian Dansereau et al
Alzheimers Dement (Amst) 2017; 8: 73–85
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436069/
■ Choroidal thinning: Alzheimer´s disease and aging
João Paulo Cunha, Rita Proença, Arnaldo Dias-Santos et al
Alzheimers Dement (Amst) 2017; 8: 11–17
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390660/
■ Alzheimer disease: Scientific Breakthroughs and translational challenges
R J Caselli, T G Beach, D S Knopman, N R Graff-Radford
Mayo Clinic Proceedings 2017, vol 92 (6): 978-994
http://www.mayoclinicproceedings.org/article/S0025-6196(17)30158-1/fulltext
■ Sleep, cognitive impairment, and Alzheimer´s disease: a systematic review and meta-analysis
O M Bubu, M Brannick, J Mortimer et al
Sleep 2017, vol 40 (1)
https://academic.oup.com/sleep/article/2661823/Sleep-Cognitive-impairment-and-Alzheimer-s-disease
■ Use it or lose it! Cognitive activity as a protective factor for cognitive decline associated with Alzheimer´s disease
P Mistridis, J Mata, S Neuner-Jehle et al
Swiss Med Wkly 2017, vol 147: w14407
https://smw.ch/en/article/doi/smw.2017.14407/
■ Optimal nonpharmacological management of agitation in Alzheimer´s disease: challenges and solutions
José Carlos Millán-Calenti, Laura Lorenzo-López, Begoña Alonso-Búa et al
Clin Interv Aging. 2016; 11: 175–184.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769004/
■ Odor identification as a biomarker of preclinical AD in older adults at risk
M Lafaille-Magnan, J Poirier, P Etienne et al
Neurology 2017, vol 89: 327-335
http://www.neurology.org/content/early/2017/06/28/WNL.0000000000004159.full.pdf
■ Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study
B Imtiaz, M Tuppurainen, T Rikkonen et al
Neurology 2017, vol 88: 1062-1068
http://www.neurology.org/content/early/2017/02/15/WNL.0000000000003696.full.pdf+html
■ Dieta mediterránea y sus efectos benéficos en la prevención de la enfermedad de Alzheimer.
L Miranda, Arnoldo, Gómez-Gaete, Carolina and Mennickent, Sigrid
Rev. méd. Chile, Abr 2017, vol.145, no.4, p.501-507
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000400010&lng=es&nrm=iso
■ Increased white matter inflammation in aging and Alzheimer´s disease brain
Raj D, Yin Z, Breur M et al
Front Mol Neurosci. 2017 Jun 30;10:20
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492660/
■ Transethnic genome-wide scan identifies novel Alzheimer´s disease loci
Gyungah R. Jun, Jaeyoon Chung, Jesse Mez
Alzheimer & Dementia 2017, vol 13 (7): 727-738
http://www.alzheimersanddementia.com/article/S1552-5260(17)30003-1/fulltext
■ Disease progression in mild dementia due to Alzheimer disease in na 18-month observational study (GERAS): the impact on costs and caregiver outcomes
Roy W. Jones, Jeremie Lebrec, Kristin Kahle-Wrobleski, et al
Dement Geriatr Cogn Dis Extra. 2017 Jan-Apr; 7(1): 87–100
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465649/
■ How do community-dwelling persons with Alzheimer disease fall? Falls in the FINALEX Studyy
Niko M. Perttila, Hannareeta Öhman, Timo E. Strandberg et al
Dement Geriatr Cogn Dis Extra. 2017 May-Aug; 7(2): 195–203
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498949/
■ Early-versus late-onset Alzheimer disease: long-term functional outcomes, nursing home placement, and risk factors for rate of progression
Carina Wattmo, Åsa K. Wallin
Dement Geriatr Cogn Dis Extra. 2017 Jan-Apr; 7(1): 172–18
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471791/
■ Serum amino acid profiles in normal subjects and in patients with or at risk of Alzheimer dementia
Gaetano Corso, Adriana Cristofano, Nadia Sapere et al
Dement Geriatr Cogn Dis Extra. 2017 Jan-Apr; 7(1): 143–159
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471778/
■ TDP-43, mixed pathologies, and clinical Alzheimer´s type dementia
B D James, R S Wilson, P A Boyle et al
Brain 2016, vol 139 (11): 2983-2993
■ Effects of ageing and Alzhemier disease no haemodynamic response function: a challenge for event-related Fmri
Davud Asemani, Hassan Morsheddost, Mahsa Alizadeh Shalchy
Healthc Technol Lett. 2017, vol 4(3): 109–114
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496466/
■ Alzheimer disease
Liana G. Apostolova
Continuum (Minneap Minn) 2016 Apr; 22(2 Dementia): 419–434
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390933/
■ Legal medical consideration of Alzhemier´s disease patients dysgraphia and cognitive dysfunction: a 6 month follow up
Emanuela Onofri, Marco Mercuri, Trevor Archer et al
Clin Interv Aging. 2016; 11: 279–284.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788358/
■ Big data to smart data in Alzheimer´s disease: the brain health modeling initiative
Hugo Geerts, Penny A. Dacks, Viswanath Devanarayan et al
Alzheimer & Dementia 2016, vol 12 (9): 1014-1021
http://www.alzheimersanddementia.com/article/S1552-5260(16)30246-1/fulltext
■ Genetic risk factors for the posterior cortical atrophy variant of Alzhemier´s
J M Schott, S J Crutch, M M Carrasquillo et al
Alzheimer & Dementia 2016, vol 12 (8): 862-871
http://www.alzheimersanddementia.com/article/S1552-5260(16)00077-7/fulltext
■ Electroencephalography-driven approach to prodromal Alzheimer´s disease diagnosis: from biomarker integration to network-level comprehension
Davide Vito Moretti
Clin Interv Aging. 2016; 11: 897–912
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939982/
■ Alzheimer´s disease risk variantes modultates endophenotypes in mild cognitive
Eva Louwersheimer, Steffen Wolfsgruber, Ana Espinosa et al
Alzheimer & Dementia 2016, vol 12 (8): 872-881
http://www.alzheimersanddementia.com/article/S1552-5260(16)00046-7/fulltext
■ Doença de Alzheimer: novas diretrizes para o diagnóstico
B O Nitzsche, H P de Moraes, A R Tavares Júnior
Rev Med Minas Gerais 2015, vol 25 (2): 237-243